Pathophysiology of copd

Asthma and COPD

Volumn , Issue , 2009, Pages 425-442

  Barnes, Peter J ^a   Rennard, Stephen I ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953094454     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374001-4.00034-1     Document Type: Chapter

References (102)

1. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of COPD-2006 update. Am J Respir Crit Care Med 2007, 176:532-555.
2. Mannino D.M., Buist A.S. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 2007, 370:765-773.
3. Lokke A., Lange P., Scharling H., Fabricius P., Vestbo J. Developing COPD: A 25 year follow up study of the general population. Thorax 2006, 61:935-939.
4. Rennard S.I., Vestbo J. COPD: The dangerous underestimate of 15%. Lancet 2006, 367:1216-1219.
5. O'Donnell D.E., Laveneziana P. Dyspnea and activity limitation in COPD: Mechanical factors. COPD 2007, 4:225-236.
6. Makita H., Nasuhara Y., Nagai K., Ito Y., Hasegawa M., Betsuyaku T., et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax 2007, 62:932-937.
7. Sturton G., Persson C., Barnes P.J. Small airways: An important but neglected target in the treatment of obstructive airway diseases 2008, Trends Pharmacol Sci.
8. Zhang J.J., Smith K.R. Household air pollution from coal and biomass fuels in China: Measurements, health impacts, and interventions. Environ Health Perspect 2007, 115:848-855.
9. Yin P., Jiang C.Q., Cheng K.K., Lam T.H., Lam K.H., Miller M.R., et al. Passive smoking exposure and risk of COPD among adults in China: The Guangzhou Biobank Cohort Study. Lancet 2007, 370:751-757.
10. Donaldson G.C., Seemungal T.A., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57:847-852.
11. Sethi S., Murphy T.F. Bacterial infection in chronic obstructive pulmonary disease in 2000: A state-of-the-art review. Clin Microbiol Rev 2001, 14:336-363.
12. Marossy A.E., Strachan D.P., Rudnicka A.R., Anderson H.R. Childhood chest illness and the rate of decline of adult lung function between ages 35 and 45 years. Am J Respir Crit Care Med 2007, 175:355-359.
13. Higashimoto Y., Elliott W.M., Behzad A.R., Sedgwick E.G., Takei T., Hogg J.C., et al. Inflammatory mediator mRNA expression by adenovirus E1A-transfected bronchial epithelial cells. Am J Respir Crit Care Med 2002, 166:200-207.
14. Petrache I., Diab K., Knox K.S., Twigg H.L., Stephens R.S., Flores S., et al. HIV associated pulmonary emphysema: A review of the literature and inquiry into its mechanism. Thorax 2008, 63:463-469.
15. Fletcher C., Peto R. The natural history of chronic airflow obstruction. BMJ 1977, 1:1645-1648.
16. Morla M., Busquets X., Pons J., Sauleda J., Macnee W., Agusti A.G. Telomere shortening in smokers with and without COPD. Eur Respir J 2006, 27:525-528.
17. Nyunoya T., Monick M.M., Klingelhutz A., Yarovinsky T.O., Cagley J.R. Hunninghake GW. Cigarette smoke induces cellular senescence. Am J Respir Cell Mol Biol 2006, 35:681-688.
18. Holz O., Zuhlke I., Jaksztat E., Muller K.C., Welker L., Nakashima M., et al. Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture. Eur Respir J 2004, 24:575-579.
19. Muller K.C., Welker L., Paasch K., Feindt B., Erpenbeck V.J., Hohlfeld J.M., et al. Lung fibroblasts from patients with emphysema show markers of senescence in vitro. Respir Res 2006, 7:32.
20. Sato A., Hirai T., Imura A., Kita N., Iwano A., Muro S., et al. Morphological mechanism of the development of pulmonary emphysema in klotho mice. Proc Natl Acad Sci USA 2007, 104:2361-2365.
21. Sato T., Seyama K., Sato Y., Mori H., Souma S., Akiyoshi T., et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging and smoking. Am J Respir Crit Care Med 2006, 174:530-537.
22. Rennard S.I., Togo S., Holz O. Cigarette smoke inhibits alveolar repair: A mechanism for the development of emphysema. Proc Am Thorac Soc 2006, 3:703-708.
23. Sahebjami H., Domino M. Effects of starvation and refeeding on elastase-induced emphysema. J Appl Physiol 1989, 66:2611-2616.
24. Laurent P., JanoffA., Kagan H.M. Cigarette smoke blocks cross-linking of elastin in vitro. Chest 1983, 83:63S-65S.
25. Kasahara Y., Tuder R.M., Taraseviciene-Stewart L., Le Cras T.D., Abman S., Hirth P.K., et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2006, 106:1311-1319.
26. Togo S., Holz O., Liu X., Sugiura H., Kamio K., Wang X., et al. Lung fibroblast repair functions in COPD patients are altered by multiple mechanisms 2008, Am J Respir Crit Care Med.
27. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliott W.M., Buzatu L., et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653.
28. Barnes P.J., Shapiro S.D., Pauwels R.A. Chronic obstructive pulmonary disease: Molecular and cellular mechanisms. Eur Respir J 2003, 22:672-688.
29. Barnes P.J. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004, 56:515-548.
30. Donnelly L.E., Barnes P.J. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. Trends Pharmacol Sci 2006, 27:546-553.
31. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008, 8:183-192.
32. Fabbri L.M., Romagnoli M., Corbetta L., Casoni G., Busljetic K., Turato G., et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 167:418-424.
33. Papi A., Romagnoli M., Baraldo S., Braccioni F., Guzzinati I., Saetta M., et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162:1773-1777.
34. Jeffery P.K. Comparison of the structural and inflammatory features of COPD and asthma. Chest 2000, 117:251S-260S.
35. Rogers D.F. The role of airway secretions in COPD: Pathophysiology, epidemiology and pharmacotherapeutic options. COPD 2005, 2:341-353.
36. Willemse B.W., ten Hacken N.H., Rutgers B., Lesman-Leegte I.G., Postma D.S., Timens W. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J 2005, 26:835-845.
37. Gamble E., Grootendorst D.C., Hattotuwa K., O'Shaughnessy T., Ram F.S., Qiu Y., et al. Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: A pooled analysis. Eur Respir J 2007, 30:467-471.
38. Franklin W.A., Veve R., Hirsch F.R., Helfrich B.A., Bunn P.A. Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol 2002, 29:3-14.
39. Mio T., Nagai S., Kitaichi M., Kawatani A., Izumi T. Proliferative characteristics of fibroblast lines derived from open lung biopsy specimens of patients with IPF (UIP). Chest 1992, 102:832-837.
40. Miki H., Mio T., Nagai S., Hoshino Y., Nagao T., Kitaichi M., et al. Fibroblast contractility: Usual interstitial pneumonia and nonspecific interstitial pneumonia. Am J Respir Crit Care Med 2000, 162:2259-2264.
41. Keatings V.M., Collins P.D., Scott D.M., Barnes P.J. Differences in interleukin-8 and tumor necrosis factor-a in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996, 153:530-534.
42. 1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996, 51:267-271.
43. Vlahos R., Bozinovski S., Hamilton J.A., Anderson G.P. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). Pharmacol Ther 2006, 112:106-115.
44. Di Stefano A., Maestrelli P., Roggeri A., Turato G., Calabro S., Potena A., et al. Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med 1994, 149:803-810.
45. Traves S.L., Culpitt S., Russell R.E.K., Barnes P.J., Donnelly L.E. Elevated levels of the chemokines GRO-a and MCP-1 in sputum samples from COPD patients. Thorax 2002, 57:590-595.
46. Keatings V.M., Barnes P.J. Granulocyte activation markers in induced sputum: Comparison between chronic obstructive pulmonary disease, asthma and normal subjects. Am J Respir Crit Care Med 1997, 155:449-453.
47. Biernacki W.A., Kharitonov S.A., Barnes P.J. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003, 58:294-298.
48. Aaron S.D., Angel J.B., Lunau M., Wright K., Fex C., Le Saux N., et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:349-355.
49. Barnes P.J. Macrophages as orchestrators of COPD. COPD 2004, 1:59-70.
50. Retamales I., Elliott W.M., Meshi B., Coxson H.O., Pare P.D., Sciurba F.C., et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001, 164:469-473.
51. Meshi B., Vitalis T.Z., Ionescu D., Elliott W.M., Liu C., Wang X.D., et al. Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol 2002, 26:52-57.
52. Russell R.E., Thorley A., Culpitt S.V., Dodd S., Donnelly L.E., Demattos C., et al. Alveolar macrophage-mediated elastolysis: Roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol 2002, 283:L867-lL873.
53. Caramori G., Romagnoli M., Casolari P., Bellettato C., Casoni G., Boschetto P., et al. Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax 2003, 58:348-351.
54. Traves S.L., Smith S.J., Barnes P.J., Donnelly L.E. Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: A role for CXCR2. J Leukoc Biol 2004, 76:441-450.
55. Grumelli S., Corry D.B., Song L-X., Song L., Green L., Huh J., et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004, 1:75-83.
56. Tomita K., Caramori G., Lim S., Ito K., Hanazawa T., Oates T., et al. Increased p21CIP1/WAF1 and B cell lymphoma leukemia-xL expression and reduced apoptosis in alveolar macrophages from smokers. Am J Respir Crit Care Med 2002, 166:724-731.
57. Keatings V.M., Jatakanon A., Worsdell Y.M., Barnes P.J. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997, 155:542-548.
58. Culpitt S.V., Rogers D.F., Shah P., de Matos C., Russell R.E., Donnelly L.E., et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 167:24-31.
59. Ito K., Ito M., Elliott W.M., Cosio B., Caramori G., Kon O.M., et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005, 352:1967-1976.
60. Barnes P.J. Reduced histone deacetylase in COPD: Clinical implications. Chest 2006, 129:151-155.
61. Zhu J., Qiu Y.S., Majumdar S., Gamble E., Matin D., Turato G., et al. Exacerbations of Bronchitis: Bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. Am J Respir Crit Care Med 2001, 164:109-116.
62. Hammad H., Lambrecht B.N. Dendritic cells and epithelial cells: Linking innate and adaptive immunity in asthma. Nat Rev Immunol 2008, 8:193-204.
63. Rogers A.V., Adelroth E., Hattotuwa K., Dewar A., Jeffery P.K. Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: An electron microscopic study 2007, Thorax.
64. Di Stefano A., Caramori G., Capelli A., Gnemmi I., Ricciardolo F., Oates T., et al. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J 2004, 24:78-85.
65. Barnes P.J., Cosio M.G. Characterization of T lymphocytes in chronic obstructive pulmonary disease. PLoS Med 2004, 1:25-27.
66. Costa C., Rufino R., Traves S.L., Silva L.E., Barnes P.J., Donnelly L.E. CXCR3 and CCR5 chemokines in the induced sputum from patients with COPD. Chest 2008, 133:26-33.
67. Saetta M., Mariani M., Panina-Bordignon P., Turato G., Buonsanti C., Baraldo S., et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 165:1404-1409.
68. Cosio M.G., Majo J., Cosio M.G. Inflammation of the airways and lung parenchyma in COPD: Role of T cells. Chest 2002, 121:160S-165S.
69. Takubo Y., Guerassimov A., Ghezzo H., Triantafillopoulos A., Bates J.H., Hoidal J.R., et al. Alpha1-antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: Parallels with human disease. Am J Respir Crit Care Med 2002, 166:1596-1603.
70. Hashimoto S., Kobayashi A., Kooguchi K., Kitamura Y., Onodera H., Nakajima H. Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med 2000, 161:237-243.
71. + lymphocytes in patients with COPD. Chest 2004, 125:71-76.
72. Majo J., Ghezzo H., Cosio M.G. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001, 17:946-953.
73. Cosio M.G. T-lymphocytes. Chronic Obstructive Pulmonary disease: Cellular and Molecular mechanisms 2005, 321-325. Taylor & Francis Group, New York. P.J. Barnes (Ed.).
74. + T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005, 172:590-596.
75. Lee S.H., Goswami S., Grudo A., Song L.Z., Bandi V., Goodnight-White S., et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007, 13:567-569.
76. Barczyk A., Pierzchala W., Kon O.M., Cosio B., Adcock I.M., Barnes P.J. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. J Allergy Clin Immunol 2006, 117:1484-1492.
77. Fairclough L., Urbanowicz R.A., Corne J., Lamb J.R. Killer cells in chronic obstructive pulmonary disease. Clin Sci (Lond) 2008, 114:533-541.
78. Vijayanand P., Seumois G., Pickard C., Powell R.M., Angco G., Sammut D., et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med 2007, 356:1410-1422.
79. Montuschi P., Kharitonov S.A., Ciabattoni G., Barnes P.J. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003, 58:585-588.
80. Beeh K.M., Kornmann O., Buhl R., Culpitt S.V., Giembycz M.A., Barnes P.J. Neutrophil chemotactic activity of sputum from patients with COPD: Role of interleukin 8 and leukotriene B4. Chest 2003, 123:1240-1247.
81. Rahman I. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: Cellular and molecular mechanisms. Cell Biochem Biophys 2005, 43:167-188.
82. Montuschi P., Barnes P.J., Roberts L.J. Isoprostanes: Markers and mediators of oxidative stress. FASEB J 2004, 18:1791-1800.
83. Rangasamy T., Cho C.Y., Thimmulappa R.K., Zhen L., Srisuma S.S., Kensler T.W., et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 2004, 114:1248-1259.
84. Ishii Y., Itoh K., Morishima Y., Kimura T., Kiwamoto T., Iizuka T., et al. Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol 2005, 175:6968-6975.
85. Tomita K., Barnes P.J., Adcock I.M. The effect of oxidative stress on histone acetylation and IL-8 release. Biochem Biophys Res Commun 2003, 301:572-577.
86. Ito K., Tomita T., Barnes P.J., Adcock I.M. Oxidative stress reduces histone deacetylase (HDAC)2 activity and enhances IL-8 gene expression: Role of tyrosine nitration. Biochem Biophys Res Commun 2004, 315:240-245.
87. Brindicci C., Ito K., Resta O., Pride N.B., Barnes P.J., Kharitonov S.A. Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J 2005, 26:52-59.
88. Ricciardolo F.L., Caramori G., Ito K., Capelli A., Brun P., Abatangelo G., et al. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. J Allergy Clin Immunol 2005, 116:1028-1035.
89. Barnes P.J. Cytokine networks in asthma and chronic obstructive pulmonary disease 2008, J Clin Invest.
90. Boivin G.P., Ormsby I., Jones-Carson J., O'Toole B.A., Doetschman T. Germ-free and barrier-raised TGF beta 1-deficient mice have similar inflammatory lesions. Transgenic Res 1997, 6:197-202.
91. Bonniaud P., Kolb M., Galt T., Robertson J., Robbins C., Stampfli M., et al. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol 2004, 173:2099-2108.
92. Shao M.X., Nakanaga T., Nadel J.A. Cigarette smoke Induces MUC5AC mucin overproduction via tumor necrosis factor-a converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol 2004, 287:L420-L427.
93. Burgel P.R., Nadel J.A. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 2004, 59:992-996.
94. Rothenberg M.E. VEGF obstructs the lungs. Nat Med 2004, 10:1041-1042.
95. Petrache I., Natarajan V., Zhen L., Medler T.R., Richter A.T., Cho C., et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005, 11:491-498.
96. Russell R.E., Culpitt S.V., DeMatos C., Donnelly L., Smith M., Wiggins J., et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002, 26:602-609.
97. Hautamaki R.D., Kobayashi D.K., Senior R.M., Shapiro S.D. Requirement for macrophage metalloelastase for cigarette smoke-induced emphysema in mice. Science 1997, 277:2002-2004.
98. Imai K., Dalal S.S., Chen E.S., Downey R., Schulman L.L., Ginsburg M., et al. Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 2001, 163:6-91.
99. Agusti A. Chronic obstructive pulmonary disease: A systemic disease. Proc Am Thorac Soc 2006, 3:478-481.
100. van Eeden S.F., Sin D.D. Chronic obstructive pulmonary disease: A chronic systemic inflammatory disease. Respiration 2008, 75:224-238.
101. Barnes P.J., Hansel T.T. Prospects for new drugs for chronic obstructive pulmonary disease. Lancet 2004, 364:985-996.
102. Rabe K.F., Beghe B., Luppi F., Fabbri L.M. Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med 2007, 175:1222-1232.